Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19

Clinical trial NCT04477993 · TERMINATED

Trial details

NCT number: NCT04477993
Sponsor: Vanderson Geraldo Rocha
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV2

Start date: 2020-08-14
Primary completion: 2021-03-29
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.